SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G |
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
Immunocore Holdings plc (Name of Issuer) |
Ordinary shares, nominal value of GBP0.002 per share (Title of Class of Securities) |
45258D105 (CUSIP Number) |
12/31/2024 (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
![]() |
![]() |
![]() |
SCHEDULE 13G
|
CUSIP No. | 45258D105 |
1 | Names of Reporting Persons
Jallal Bahija | ||||||||
2 | Check the appropriate box if a member of a Group (see instructions)
![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting Person
4,493,139.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
![]() | ||||||||
11 | Percent of class represented by amount in row (9)
8.2 % | ||||||||
12 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13G
|
Item 1. | ||
(a) | Name of issuer:
Immunocore Holdings plc | |
(b) | Address of issuer's principal executive offices:
92 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom, OX14 4RY | |
Item 2. | ||
(a) | Name of person filing:
Bahija Jallal, Ph.D. | |
(b) | Address or principal business office or, if none, residence:
The address and principal business office of the Reporting Person is:
c/o Immunocore Holdings plc
92 Park Drive, Milton Park
Abingdon, Oxfordshire OX14 4RY
United Kingdom | |
(c) | Citizenship:
United States | |
(d) | Title of class of securities:
Ordinary shares, nominal value of GBP0.002 per share | |
(e) | CUSIP No.:
45258D105 | |
Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
(a) | ![]() | |
(b) | ![]() | |
(c) | ![]() | |
(d) | ![]() | |
(e) | ![]() | |
(f) | ![]() | |
(g) | ![]() | |
(h) | ![]() | |
(i) | ![]() | |
(j) | ![]() please specify the type of institution: | |
(k) | ![]() | |
Item 4. | Ownership | |
(a) | Amount beneficially owned:
As of December 31, 2024, Dr. Jallal was the beneficial owner of 4,493,139 ordinary shares, consisting of 4,493,139 ordinary shares underlying outstanding options held by Dr. Jallal that are or will be exercisable within 60 days of December 31, 2024. | |
(b) | Percent of class:
8.2%, which is based on a total of 50,032,770 ordinary shares (including ordinary shares in the form of American Depositary Shares) outstanding as of October 31, 2024, as reported by the Issuer in its Form 10-Q for the quarter ended September 30, 2024, filed with the United States Securities and Exchange Commission on November 6, 2024. %
| |
(c) | Number of shares as to which the person has:
| |
(i) Sole power to vote or to direct the vote:
4,493,139 | ||
(ii) Shared power to vote or to direct the vote:
0 | ||
(iii) Sole power to dispose or to direct the disposition of:
4,493,139 | ||
(iv) Shared power to dispose or to direct the disposition of:
0 | ||
Item 5. | Ownership of 5 Percent or Less of a Class. | |
Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
Item 9. | Notice of Dissolution of Group. | |
Not Applicable
|
Item 10. | Certifications: |
Not Applicable
|
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|